Dr. Kenichi Fujise, MD

Dr. Fujise practices at Harborview Medical Center in Seattle, Washington, part of University of Washington.

Dr. Fujise's NPI, 1861426009, was assigned on July 11, 2006. Dr. Fujise holds Washington license MD61004692.

Dr. Fujise's primary practice is Harborview Medical Center, at 325 9th Avenue, Seattle, WA 98104 in King County. The practice phone is (206) 744-9535.

Dr. Fujise's primary practice is Harborview Medical Center in Seattle, Washington, part of University of Washington. Dr. Fujise is also affiliated with John Sealy Hospital. The medical group on file is UW Physicians. Dmand AI also links Dr. Fujise to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fujise practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Fujise's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Fujise's licenses on file in 2 states: Washington and Texas.

CMS data shows 404 Medicare services from Dr. Fujise across 3 procedure codes in 2024, for 310 Medicare patients. Medicare paid $5,603 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 310 Medicare patients who saw Dr. Fujise in 2024. The largest group is 65 to 74, with 106 patients. 75% of them have high blood pressure, and 65% have high cholesterol. 39% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fujise's median patient age at 60, with 43% women.

In 2024, Dr. Fujise wrote 161 Medicare Part D claims for 23 patients. 90% of them were for generic drugs. CMS names the drug for 116 of them, across 6 drugs with 11 or more claims each, at $963 in total drug cost. In 2020, CMS named 135 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Fujise for performance year 2024, reported through an alternative payment model (APM). Dr. Fujise accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 55 general payments to Dr. Fujise from 13 drug and device companies from 2016 to 2021. Speaker and faculty fees make up the largest share, 62% of the total. St. Jude Medical, Inc. paid the most, $6,178.